ResearcherChina Pharmaceutical UniversityNo recent work listed

Shengtao Yuan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2714-4197; OpenAlex author ID A5100719493. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper

Papers 1

Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that interfere the binding between KRAS and G… Last author DOI 10.1016/j.ejphar.2023.176157 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yannan Xia · 1 shared paper, 2023 · strength 0.20
- Paper Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that … DOI 10.1016/j.ejphar.2023.176157 ↗
Yumeng Wang · 1 shared paper, 2023 · strength 0.20
- Paper Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that … DOI 10.1016/j.ejphar.2023.176157 ↗
Yuanyuan Jiang · 1 shared paper, 2023 · strength 0.20
- Paper Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that … DOI 10.1016/j.ejphar.2023.176157 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.